Cbx4 suppresses CD8+ T cell anti-tumor immunity by reprogramming glycolysis metabolism
Cbx4 is involved in the regulation of CD8+ T cell metabolism in tumor tissues, which provides a new insight into T cell effector functions and tumor immunotherapy.